Culture

Healthcare protections for LGBTQ persons may broaden under Biden administration

image: Valarie Blake

Image: 
West Virginia University

Healthcare sex discrimination protections for the LGBTQ community may be expanded under the Biden Administration, including safeguards against verbal abuse, physical abuse and the denial of bedside care, according to West Virginia University College of Law experts.

In a report published in California Law Review, Professor Valarie Blake and students Ashley Stephens and Amy Post examined whether gender identity and sexual orientation should be included in healthcare sex discrimination laws, on the heels of the historic 2020 Supreme Court case Bostock v. Clayton County.

In that case, the Court ruled that sex discrimination includes gender identity and sexual orientation when it comes to employment standards. Yet the interpretation of whether it extends into healthcare access is vague.

Bostock's reach will be litigated frequently in the coming months, Blake said, and the Biden administration will likely introduce a new rule broadening LGBTQ rights that will inevitably lead to further legal challenges.

Ultimately, the Supreme Court may need to decide the matter, Blake and her co-authors wrote. Bostock necessitates the view that health care entities receiving federal funds cannot discriminate against individuals on the basis of LGBTQ identity, they said.

The Bostock decision had prompted Stephens and Post to discuss those implications in the West Virginia Medical Journal. Blake then partnered with the students to produce a deeper dive into the issues surrounding sex discrimination in the California Law Review paper.

"In any context, he (Justice Neil Gorsuch) basically says that if you discriminate on sex, you are always discriminating based on sexual orientation or transgender status, because those are intrinsically linked with sex," Blake said. "And so looking at that, the Court only decided on employment law, but we have other areas - like healthcare - where sex discrimination has still been not defined. And in which Gorsuch's opinion appears to resolve any uncertainty that LGBTQ discrimination is sex discrimination and must be forbidden under the law."

The authors believe discrimination in a healthcare setting can have a lasting impact on an LGBTQ person. Someone with a negative experience at a care facility is likely to avoid seeking medical help in the future, they said.

Healthcare protections were first introduced under the Obama Administration in 2010 with Section 1557 of the Affordable Care Act, banning sex discrimination. However, they weren't solidified for the LGBTQ community until 2016 when the Department of Health and Human Services stated that the statute included the community in a broad sense.

The inclusion of gender identity and sexual orientation sparked backlash among several religious organizations and some states that argued that healthcare professionals could deny services based on religious exemptions.

Additionally, in 2020 the Trump Administration stripped gender identity and sexual orientation from Section 1557, leaving the LGBTQ community unprotected. However, according to Post, the Bostock case essentially challenges this action by the Trump administration.

"Those things shouldn't preclude you from receiving healthcare and it's kind of just like the way that we may think it's inherently obvious that a doctor shouldn't say, well, they're male, so I'm not going to help them out because I don't like men," Blake said.

"We think it should also be as inherently obvious that it doesn't matter if you identify as LGBTQ-plus, you are deserving of the care that everybody else is."

Moving forward, Stephens suggests that legislation should be explicitly written and include gender identity and sexual orientation to ensure that the LGBTQ community is covered on all platforms.

Additionally, the researchers emphasized patient advocacy and said that in order to avoid any discriminatory practices, a patient can ask if a care facility is LGBTQ friendly. This helps to ensure a positive experience and relationship between patient and provider, they said.

"What I would say is to those people who feel that they've been discriminated against, you know, show up, get your care met," Blake said. "Take care of yourself and expect that you will get that care met because you have rights and you deserve them."

Credit: 
West Virginia University

COVID-19 can kill heart muscle cells, interfere with contraction

image: A study from Washington University School of Medicine in St. Louis provides evidence that the coronavirus that causes COVID-19 can invade and replicate inside heart muscle cells, causing cell death and interfering with heart muscle contraction. The image of engineered heart tissue shows human heart muscle cells (red) infected with SARS-CoV-2 (green).

Image: 
Lina Greenberg

Since early in the pandemic, COVID-19 has been associated with heart problems, including reduced ability to pump blood and abnormal heart rhythms. But it's been an open question whether these problems are caused by the virus infecting the heart, or an inflammatory response to viral infection elsewhere in the body. Such details have implications for understanding how best to treat coronavirus infections that affect the heart.

A new study from Washington University School of Medicine in St. Louis provides evidence that COVID-19 patients' heart damage is caused by the virus invading and replicating inside heart muscle cells, leading to cell death and interfering with heart muscle contraction. The researchers used stem cells to engineer heart tissue that models the human infection and could help in studying the disease and developing possible therapies.

The study is published Feb. 26 in the Journal of the American College of Cardiology: Basic to Translational Science.

"Early on in the pandemic, we had evidence that this coronavirus can cause heart failure or cardiac injury in generally healthy people, which was alarming to the cardiology community," said senior author Kory J. Lavine, MD, PhD, an associate professor of medicine. "Even some college athletes who had been cleared to go back to competitive athletics after COVID-19 infection later showed scarring in the heart. There has been debate over whether this is due to direct infection of the heart or due to a systemic inflammatory response that occurs because of the lung infection.

"Our study is unique because it definitively shows that, in patients with COVID-19 who developed heart failure, the virus infects the heart, specifically heart muscle cells."

Lavine and his colleagues -- including collaborators Michael S. Diamond, MD, PhD, the Herbert S. Gasser Professor of Medicine, and Michael J. Greenberg, PhD, an assistant professor of biochemistry and molecular biophysics -- also used stem cells to engineer tissue that models how human heart tissue contracts. Studying these heart tissue models, they determined that viral infection not only kills heart muscle cells but destroys the muscle fiber units responsible for heart muscle contraction.

They also showed that this cell death and loss of heart muscle fibers can happen even in the absence of inflammation.

"Inflammation can be a second hit on top of damage caused by the virus, but the inflammation itself is not the initial cause of the heart injury," Lavine said.

Other viral infections have long been associated with heart damage, but Lavine said SARS-CoV-2, the virus that causes COVID-19, is unique in the effect it has on the heart, especially in the immune cells that respond to the infection. In COVID-19, immune cells called macrophages, monocytes and dendritic cells dominate the immune response. For most other viruses that affect the heart, the immune system's T cells and B cells are on the scene.

"COVID-19 is causing a different immune response in the heart compared with other viruses, and we don't know what that means yet," Lavine said. "In general, the immune cells seen responding to other viruses tend to be associated with a relatively short disease that resolves with supportive care. But the immune cells we see in COVID-19 heart patients tend to be associated with a chronic condition that can have long-term consequences. These are associations, so we will need more research to understand what is happening."

Part of the reason these questions of causation in heart damage have been hard to answer is the difficulty in studying heart tissue from COVID-19 patients. The researchers were able to validate their findings by studying tissue from four COVID-19 patients who had heart injury associated with the infection, but more research is needed.

To that end, Lavine and Diamond, are working to develop a mouse model of the heart injury. To emphasize the urgency of the work, Lavine pointed to the insidious nature of the heart damage COVID-19 can cause.

"Even young people who had very mild symptoms can develop heart problems later on that limit their exercise capacity," Lavine said. "We want to understand what's happening so we can prevent it or treat it. In the meantime, we want everyone to take this virus seriously and do their best to take precautions and stop the spread, so we don't have an even larger epidemic of preventable heart disease in the future."

Credit: 
Washington University School of Medicine

A genetic patch to prevent hereditary deafness

They can hear well up to about forty years old, but then suddenly deafness strikes people with DFNA9. The cells of the inner ear can no longer reverse the damage caused by a genetic defect in their DNA. Researchers at Radboud university medical center have now developed a "genetic patch" for this type of hereditary deafness, with which they can eliminate the problems in the hearing cells. Further research in animals and humans is needed to bring the genetic patch to the clinic as a therapy.

Hereditary deafness can manifest itself in different ways. Often the hereditary defect (mutation) immediately causes deafness from birth. Sometimes, as with DFNA9, you experience the initial problems in hearing after forty, fifty, sixty years. This has everything to do with the way DFNA9 mechanistically works. Every person gets half of his genes from his father and the other half from his mother. If you have two healthy copies of the DFNA9 gene, your inner ear works normal. If you receive a mutated copy of the gene from either your father or mother, deafness will develop later in life.

Protein spaghetti

Erik de Vrieze and Erwin van Wijk, both researchers at Hearing & Genes of the department of Ear, Nose and Throat, have conducted extensive research into the condition. De Vrieze: "We now know that you actually produce enough of the associated DFNA9 protein with just one healthy gene copy to be able to hear well for life. But there is a catch with this condition. The mutated protein is, in a way, disturbing the function of the healthy protein. It sticks to it, so that the healthy protein can also no longer do its job. This clumped protein spaghetti is constantly being removed by the cells of the inner ear, but after decades the clean-up service in these cells is reaching its limit and can no longer cope with these protein clumps. A threshold value is exceeded. As a result, the waste accumulates, the hearing cells start to function poorly and even die over time. After years of normal hearing, DFNA9 patients suddenly notice that their hearing is deteriorating, and sometimes deteriorating very quickly. Until at some point they will become deaf. "

Enough time for treatment

The specific DFNA9 mutation seems to originate from a common ancestor in the Southern Netherlands, somewhere at the end of the Middle Ages. This can more or less be deduced from the spread of the fairly unique clinical manifestation, which is now estimated to occur in about 1500 people in the (southern) Netherlands and Belgium. Perhaps even more important than the origin of the disease is whether or not anything can be done about it. Van Wijk: "This condition has two favorable characteristics for therapy development. Firstly, it is a hereditary condition that only manifests itself after a few decades in life. In case an effective treatment will become available for this disease, a sufficiently large timeframe is available to apply it before the hearing loss really strikes. "

Turning off mutant gene

The other point - developing an effective therapy - is a bit more complicated, but offers good starting points. Van Wijk: "The idea is that by specifically turning off the mutated gene copy you can prevent deafness. Without this mutated gene copy, no mutant protein will be produced and protein clumping will no longer take place. In addition, one healthy gene copy alone produces enough protein to maintain good hearing. "

Genetic patch

De Vrieze and Van Wijk further developed this idea. Together with colleagues, they have now published the research results in the scientific journal Molecular Therapy - Nucleic Acids. "Genes, that reside on our DNA, provide the genetic code for the translation process into proteins," says De Vrieze. "To get from a gene to a protein, you always need a translation process via so-called messenger RNA. And that is exactly the process we focused on. The unique DNA error in the DFNA9 gene is also reflected in the RNA. We developed a small piece of RNA that specifically binds to the messenger RNA derived from the mutated DFNA9 gene. As a result, the entire mutated messenger RNA is targeted for degradation. In this way, an essential link is lost and the mutant DFNA9 protein is no longer or hardly produced. The piece of RNA that we stick on the mutated DFNA9 messenger RNA is named an antisense oligonucleotide or "genetic patch".

Perspective!

In recent years, De Vrieze and Van Wijk have not only developed this genetic patch, but also investigated its effect in cultured cells. Their current article is mainly describing these results, as the approach works in cultured cells. So there is a "proof of concept", as it is called in science. In short, the research shows that the approach works at the cellular level.

Arthur Robbesom of the "The Ninth of ..." DFNA9 Foundation is delighted with the study. "This offers a real perspective for about 1,500 people in the Netherlands and Belgium who are suffering from this condition. "The foundation is also closely involved in this research. Robbesom:" Now it is important to take the next necessary steps in the research as soon as possible. We will wholeheartedly support you."

Credit: 
Radboud University Medical Center

Deep immune profiling shows significant immune activation in children with MIS-C

Philadelphia, March 2, 2021--Taking the first deep dive into how the immune system is behaving in patients with multisystem inflammatory syndrome in children (MIS-C), researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have found that children with this condition have highly activated immune systems that, in many ways, are more similar to those of adults with severe COVID-19. The results, published today in Science Immunology, show that better understanding the immune activation in patients with MIS-C could not only help better treat those patients but also improve treatment for adults with severe COVID-19.

"This study shows that children with MIS-C are tremendously immune activated, particularly when it comes to CD8 T cells, but that this activation subsides once patients begin to improve clinically," said Laura Vella, MD, PhD, attending physician in the Division of Infectious Diseases at CHOP and first author of the study. "Our findings provide a broad immunologic foundation for understanding pathogenesis and recovery in this novel SARS-CoV-2-associated inflammatory syndrome, with potential implications for adult disease."

Pediatricians first recognized MIS-C in April 2020, when pediatric patients began presenting with symptoms involving hyperinflammation, including fever, gastrointestinal distress and cardiogenic shock. The syndrome, thought to be a post-infectious complication of SARS-CoV-2 infection, has similarities in clinical presentation to Kawasaki disease, especially the vascular involvement, but it differs from Kawasaki disease in key ways, including unique clinical, inflammatory, and autoantibody signatures. The syndrome also lacks the respiratory complications typical of adult and pediatric COVID-19. However, until this point, the immunologic features driving MIS-C remained poorly understood.

To better understand the immunology behind MIS-C, the researchers collected blood samples from patients admitted to CHOP with COVID-19 or MIS-C between April and June of 2020. They analyzed more than 200 immune parameters, including serologic and plasma cytokine data, and compared these data with samples from adult COVID-19 patients, recovered adult COVID-19 subjects, and healthy adults.

The researchers found that children with MIS-C had highly elevated T cells, particularly CD8 T cells and a highly activated vascular patrolling CD8 T cell subset. These vascular patrolling CD8 T cells have a proposed role in the control of persisting or reactivating viral infection and have also been implicated in cardiovascular disease, which could have relevance to the vascular symptoms observed in these patients. The researchers found patients with MIS-C, who all had high vascular patrolling CD8 T cells, also required vasoactive support, had elevated D-dimer, and had decreased platelets. The elevation of CD8 T cells far exceeded what the researchers observed in pediatric patients with acute COVID-19 and most adults with COVID-19, but the level of CD8 T cells dropped in MIS-C patients in conjunction with clinical improvement.

The study also highlighted a skewed B cell response in patients with MIS-C compared to acute pediatric COVID-19 and resolved adult disease. Patients with MIS-C are almost universally seropositive for SARS-CoV-2, meaning enough time had passed since infection for an antiviral antibody to develop and be detected. Pediatric and adult patients with acute COVID-19 were not seropositive, consistent with the belief that that MIS-C is a delayed event following SARS-CoV-2 infection. Yet despite MIS-C being a delayed event, the researchers found that MIS-C patients had elevated plasmablasts, or immature plasma B cells, whereas plasmablasts in adults who recover from COVID-19 return to baseline two to three weeks after symptoms resolve, although a subset of hospitalized adult patients with COVID-19 did have a sustained elevation of plasmablasts.

The researchers proposed three possible drivers of the immune pathogenesis in MIS-C: (1) continued activation of adaptive immune responses, driven by persisting SARS-CoV-2 antigen; (2) an additional trigger, such as the virus localizing to a new tissue type or a secondary infection, occurring two to three weeks after the initial infection with SARS-CoV-2; or (3) an autoimmune response. More research is needed to investigated these potential scenarios.

"SARS-CoV2 infection can lead to a broad spectrum of clinical and immunological outcomes," said E. John Wherry, PhD, Director of the Institute for Immunology and senior author of the study. "The use of an 'Immune Health' profiling approach for pediatric COVID-19 patients not only identified distinct features of the pediatric MIS-C presentation of disease, but the insights gained by studying MIS-C patients may reveal new therapeutic opportunities for pediatric and adult COVID-19 patients."

Credit: 
Children's Hospital of Philadelphia

Study of severe pediatric COVID-19 syndrome highlights differences in immune responses to SARS-CoV-2

A new study of patients with Multisystem Inflammatory Syndrome in Children (MIS-C), a rare but severe complication of COVID-19 in children, reveals distinct immune features of COVID-19 not seen in adults that may clue scientists in to why SARS-CoV-2 infection manifests differently in children compared with adults. Their results showed that although the immune landscape in pediatric COVID-19 was similar to that in adults, MIS-C patients uniquely exhibited increased activation of a blood vessel-patrolling CD8+ killer T cell subset, and all pediatric COVID-19 patients harbored greater B cell frequencies for a more prolonged period of time than observed in healthy adults. MIS-C is characterized by pervasive inflammation, an array of symptoms ranging from fever to vomiting, and insufficient blood flow throughout the body that can lead to shock. To home into the immune features of MIS-C, Laura Vella and colleagues analyzed immune responses in blood taken from 30 hospitalized SARS-CoV-2-infected pediatric patients - 14 of whom were diagnosed with MIS-C. They compared results of this analysis with samples from adult COVID-19 patients, recovered adult COVID-19 subjects, and healthy adults. While MIS-C patients exhibited patterns of decreasing T cell count and activation similar to adults with severe COVID-19, they also exhibited robust activation of a killer T cell subset that patrols and interacts with the vasculature to control viral persistence. This feature was not observed in either adult or non-MIS-C pediatric COVID-19 patients. In addition, while children with COVID-19-driven acute respiratory distress syndrome had sustained immune activation, overall immune activation in MIS-C patients decreased over time, paralleling clinical improvement. All pediatric COVID-19 patients had substantially elevated B cell frequencies compared to healthy adults, but future work will be necessary to dissect how this impacts disease. Together, these findings portray the variability in immune responses to SARS-CoV-2 across ages and patient populations and may help inform treatments for severe COVID-19 in children.

Credit: 
American Association for the Advancement of Science (AAAS)

An instructor's guide to reducing college students' stress and anxiety

image: A flowchart that identifies five strategies to help college and university instructors reduce stress and anxiety in the classroom.

Image: 
Chapman University

Orange, Calif. - Even before the COVID-19 pandemic, college students were reporting record levels of stress and anxiety. According to the American College Health Association Fall 2018 National College Health Assessment, 63% of U.S. college students experienced overwhelming anxiety throughout the year. Plus, stress can impact students' academic performance, and students with higher stress levels are more at-risk of withdrawing from college--often permanently. Given these complex mental health issues, all hands are needed on deck to support student success.

A new review from Chapman University's Schmid College of Science and Technology and Grand Challenges Initiative provides actionable and evidence-based strategies for instructors to help combat the ongoing epidemic of stress and anxiety among college and university students, with a focus on students in STEM disciplines. The strategies can be implemented by new and experienced instructors in order to reduce student stress and anxiety and ultimately improve students' academic performance and quality of life. The role that higher education instructors can play in alleviating students' stress and anxiety has been largely underexplored in previous studies, in favor of proposals for broad programmatic approaches at the institutional level.

Led by Chapman professors Jeremy Hsu and Gregory Goldsmith, the review covers specific and highly practicable actions. From learning about the university's available campus mental health programs, to arriving a few minutes prior to the start of class to allow student check-ins and greetings, to sharing relevant personal stories, the approaches in the paper directly equip the instructors who see and interact with students on a daily basis to improve the classroom experience.

We asked the authors five questions about their new review, published this week in the journal CBE--Life Sciences Education: https://www.lifescied.org/doi/10.1187/cbe.20-08-0189

Five Questions with the Authors

1.What motivated you to review best practices for reducing student stress and anxiety in the classroom?

We have always been concerned about stress and anxiety in our students and have seen how much the pandemic has exacerbated these issues. To address our concerns, we have looked for evidence-based practices to try to mitigate stress and anxiety in our classrooms and to best support our students. We wanted to bring together this research as a guide for instructors to highlight practical approaches to alleviating student stress and anxiety as they navigate these challenging circumstances.

2. You lay out a framework for instructors to alleviate stress and anxiety with five overarching approaches: learning and preparing to act; connecting with students; building an empowering classroom culture; reducing testing anxiety; and promoting effective academic skills. If you had to choose one for instructors to focus on, which would you choose and why?

Our review highlights that instructors can make a difference in alleviating student stress and anxiety through many types of interactions. For instance, it is important that instructors know and advertise the mental health resources and professional support that are available to students. Another approach involves the simple act of instructors taking a few minutes before each class to chat informally with students. Instructors can also reduce student stress and anxiety by changing the structure of their exams. Cumulatively, these small acts can add up to big improvements for students' performance in the classroom.

3. How do the approaches you identify intersect with our renewed interest in diversity, equity, and inclusion in STEM?

One of the things that stood out to us was that classroom practices that are not sensitive to equity and inclusion can disproportionately increase stress and anxiety among certain identities. Sometimes, the words or actions that seem trivial to an instructor can increase stress among certain students, and this is likely to impact their ability to learn. For instance, instructors can sometimes make statements that make students question whether they belong in the classroom and this can be a source of stress. In turn, one can also imagine that this affects whether or not a student chooses to persist in a STEM major.

4. What can universities do to support instructors in their efforts to reduce stress and anxiety in the classroom?

We are always in favor of increasing the training and support for instructors, so that they are prepared to support their students. More fundamentally, we need to normalize conversations where we talk about stress and anxiety and how we can work together so that all of our students can thrive.

5. At the end of the paper, you identify a number of areas for future research. Were there any surprises?

We have known for a while that students consistently identify stress and anxiety as barriers to their success, so in some ways, the biggest surprise was that the research on best practices in the classroom is so limited. It is also not yet clear that what works in some disciplines, or for some student demographics, will work for others. There are clearly some very exciting opportunities for experts in education and psychology to come together and provide important insights into how to improve outcomes for all of our students.

Credit: 
Chapman University

Deepwater Horizon's long-lasting legacy for dolphins

The Deepwater Horizon disaster began on April 20, 2010 with an explosion on a BP-operated oil drilling rig in the Gulf of Mexico that killed 11 workers. Almost immediately, oil began spilling into the waters of the gulf, an environmental calamity that took months to bring under control, but not before it became the largest oil spill in the history of the petroleum industry.

Nearly 10 years have passed since then, and the oil slick has long since dispersed. Yet, despite early predictions, area wildlife are still feeling the effects of that oil, and research published in Environmental Toxicology and Chemistry has shown that negative health impacts have befallen not only dolphins alive at the time of the spill, but also in their young, born years later.

A team of researchers, including UConn Department of Pathobiology Professor and Director of the Connecticut Sea Grant College Program Sylvain De Guise, is part of a network conducting a long-term study on the health of bottlenose dolphins living in Louisiana's Barataria Bay, in the vicinity of the disaster. This population of dolphins includes individuals who lived through the disaster and some born afterwards.

"We were on the ready and as soon as we could, and in 2011 we initiated a comprehensive health assessment where 60 to 80 people in the field worked together to find and safely pursue a multi-disciplinary, multi-expertise sample collection and study effort to assess the dolphins' health," says De Guise.

De Guise explains that after collection, samples were processed in 60 to 80 different specialized labs, and the researchers then regrouped to put the information together. De Guise's research group specializes in studying the immune system, and from the very first set of samples they started to see consistent and abnormal immune responses in the Barataria Bay dolphins, compared with a similar control group of dolphins from Sarasota Bay who were not exposed to oil.

For the Barataria Bay dolphins, the researchers observed immune cells called T-cells that were overly responsive to stimulation. The body uses T-cells to respond to a stimulus, or something recognized as foreign. In particular, there were increased numbers of cells called regulatory T cells, or Tregs, which De Guise describes as the cells that help put the brakes on during an immune response to prevent the body from over-responding and doing more harm than good.

Despite the elevated numbers, De Guise says they were surprised to find the Barataria Bay dolphin Tregs appear to be functionally defective.

In some ways, the immune response can be looked at almost like a relay race, with cells signaling others to respond and join in the effort. In the case of T-helper (Th) cells, important signals called cytokines determine which type of T-helper will be next in the relay, and for the Barataria Bay dolphins, the signals are not relayed as expected.

"T-helper cells decide which direction your immune system will respond. If you have a pathogen that invades cells, a virus for example, you need a T-helper1 (Th1) response that will destroy the affected cells. If you have a pathogen that does not invade cells, like most types of bacteria, you need to generate antibodies to bind to those bacteria and help eliminate them with a Th2 response," says De Guise.

In the lab, the researchers studied the immune cells from both dolphin populations by exposing them to proteins called cytokines which elicit predictable responses from the T-cells. The researchers also exposed T-cells from the control group dolphins to oil to see what would happen. In all samples of T-cells exposed to oil, Th2 responses were exaggerated compared to the control group.

"We were able to demonstrate that there was a difference in responsiveness between the populations, in both real-life and in-vitro tests which resulted in an increase in Th2 response in the Barataria Bay dolphins," says De Guise.

The researchers went one step further by conducting a mouse study to see if a similar immune response could be seen in mice exposed to oil, and they did.

"The effects on the mouse immune system that we found were strikingly similar to what we saw in the dolphins," says De Guise. "We want to show the likelihood of a cause and effect relationship and add to the weight of evidence that oil impacts the immune system in a way that is very reproducible across species. The changes that we found in the Barataria Bay dolphins is specific to oil and not related to something else."

Though the researchers are not sure if the abnormal immune response is due to the initial exposure or continued exposure to oil still present in sediments, De Guise says the result may lead to the dolphins being more susceptible to pathogens like viruses, due to dysfunctional T-reg cells. Only future studies can shed light, and De Guise says now that images of oil slicks are no longer capturing attention, funding is harder to come by.

However, for this study, De Guise notes it is very rare to have such a long-term, detailed follow-up on a wild population of animals, and the researchers were very surprised to see effects in a second generation who did not live through the disaster.

"The outcome of this work is that we are not sure if these effects are reversible or not. The longer we look, they are still around. I think it is the first time we find such evidence across generations in a wild animal population, and that is scary. It raises concern for the long-term recovery of these dolphins," says De Guise. "These are long-lived mammals and, in many ways, not unlike humans who live in the area and depend on natural resources. It is interesting science, but it is very scary."

Credit: 
University of Connecticut

Disruption of lung biological clock in premature babies may raise later flu risk

Disruptions in the circadian rhythms in lung cells may explain why adults who survived premature birth are often more at risk of severe influenza infections, suggests a study in mice published today in eLife.

Dramatic improvements in the care of infants born prematurely have allowed many more to survive into adulthood. Yet ex-preemies can face several long-term side effects of the life-saving care they received. The study suggests potential new approaches to treating lasting lung problems in those born prematurely.

Many premature infants are not able to breathe on their own and require oxygen to survive. But receiving too much oxygen may cause lasting damage to the lung that makes them more prone to severe flu infection later in life. In a previous study*, senior author and neonatologist Shaon Sengupta, and her colleagues at the Children's Hospital of Philadelphia Research Institute, Pennsylvania, US, found that susceptibility to flu in mice depended on the time of day when they caught the infection. Mice that caught the infection when they became active at dusk were more likely to die, while those infected as they went to sleep at dawn were more likely to survive. This suggests that the circadian clock, which controls the daytime and nighttime activities of the body, may offer some protection against flu.

"Given these previous findings, we wanted to see if the severity of flu infection in former premature infants may be caused by disruptions to their circadian clock," says Yasmine Issah, a former Research Technician at the Children's Hospital of Philadelphia Research Institute, and co-first author of the current study alongside Postdoctoral Research Fellow Amruta Naik.

The team began by showing that the time of day when exposure to flu occurred did not affect susceptibility to infection in adult mice that were exposed to high levels of oxygen as newborns. This suggests that these mice had lost their circadian clock-based flu protection.

But when the team tested the ability of the animals to readjust to a normal day-night schedule after living in dim light for several weeks, they found the animals had no problems - suggesting that their central circadian clock in the brain, which is regulated by exposure to daylight, was working normally.

To find out if the circadian problems were restricted to lung cells, which have their own circadian clocks separate from the brain clock, the team removed a key circadian clock gene called Bmal1 in the lung cells of normal adult mice. They eliminated the gene in the same lung cells that are damaged in newborn mice given high levels of oxygen. As with the mice that had been exposed to high oxygen as newborns, the adult animals with the deleted gene were equally susceptible to flu at dawn or dusk.

"Our findings suggest that adverse early-life exposures can disrupt the lung circadian clock," concludes Sengupta, an attending neonatologist at the Children's Hospital of Philadelphia Research Institute. "Those born prematurely are uniquely vulnerable to this faulty development of their circadian network, and this is a new paradigm for understanding the lung problems that persist into adulthood in ex-preemies. These findings could pave the way for potential new treatments that work by improving the circadian health in adults born prematurely."

Credit: 
eLife

Study: Using a warmer tone in college syllabi makes students more likely to ask for help

College course syllabi written in a warm, friendly tone are more likely to encourage students to reach out when they are struggling or need help, a new study from Oregon State University found.

Conversely, when a syllabus is written in a more cold, detached tone, students are less likely to reach out.

The study also compared the effect of syllabus tone with the effect of a deliberate "Reach out for help" statement included in the document.

"The instructor has to ask themselves, what's the first point of contact with the class for the student? In an online class and in remote learning, the syllabus is often the first thing. An impression of the course and you the instructor is formed on the syllabus," said Regan A.R. Gurung, lead author of the study and director of the general psychology program in OSU's College of Liberal Arts.

"In the old days, before Canvas and other online teaching tools, the student wouldn't see the syllabus until I handed it out. That gave me a lot of time to create that impression," he said. Now, however, students often read syllabi to determine if they want to take a course or not.

During the pandemic, when the majority of courses have moved online and students may be struggling with more stress and pressure than they would in a normal school year, conveying that it's OK to ask for help is even more important, Gurung said.

The study, published recently in the journal Teaching of Psychology, recruited 257 student volunteers from introductory psychology courses at OSU. They were tasked with reading one of four sample syllabi: warm-toned with or without a "reach out" statement, or cold-toned with or without the "reach out" statement.

The warm-toned syllabi included phrases like "I welcome you to contact me outside of class and student hours," and used more "We will" framing instead of the cold-toned version's "You will."

Student participants rated the hypothetical instructor based on the syllabus and answered some basic questions to verify they had read the document. They then ranked how likely they would be to reach out to the professor in each of five situations: help on an assignment, when feeling low, personal issues with friends or family, medical issues and to ask about campus resources.

"Reach out" statements have become more popular in recent years as a way to destigmatize mental health needs and point students toward available mental health and academic resources. But the study found that syllabus tone, more than these statements, made students more likely to seek help.

Results showed an increase in likelihood to reach out on three of the five situations among students who read the warm-tone syllabi, while students who read the syllabi with a "reach out" statement were more likely to ask for help in only one of the five situations. Warm versus cold tone had no impact on how students perceived the instructor's overall competence.

Gurung cautioned that the study is limited by being performed in lab conditions rather than in a real classroom. Researchers capped the syllabi used for the study at two pages each, when real course syllabi may be 15 pages or more. And the syllabus was the sole component for students to judge.

"But that's exactly why I think a study like this is powerful -- that even without that human component, even something as black-and-white as a syllabus can make a difference," Gurung said. "If you're a great approachable person, good for you; you'll just be able to magnify these effects."

With this study, researchers are not suggesting that professors ditch all discipline or craft an overly touchy-feely syllabus.

It's the difference between rapport and rules, Gurung said.

"You can absolutely have rules, and you should be firm and you should be fair and you should be clear, but that is sort of separate from your interaction with the student as a person," he said. "You don't have to be extroverted or cracking jokes, but you can still show that you listen."

Credit: 
Oregon State University

Study highlights pitfalls associated with 'cybervetting' job candidates

A recent study of how human resources professionals review online information and social media profiles of job candidates highlights the ways in which so-called "cybervetting" can introduce bias and moral judgment into the hiring process.

"The study drives home that cybervetting is ultimately assessing each job candidate's moral character," says Steve McDonald, corresponding author of the study and a professor of sociology at North Carolina State University. "It is equally clear that many of the things hiring professionals are looking at make it more likely for bias to play a role in hiring."

For this study, the researchers conducted in-depth interviews with 61 human resources professionals involved in recruitment and hiring across many industries. Study participants ranged from in-house HR staff to executive recruitment consultants to professionals at staffing agencies.

"One of the things that cropped up repeatedly was that cybervetting not only judges people's behavior, but how that behavior is presented," says Amanda Damarin, co-author of the paper and an associate professor of sociology at Georgia State University. "For example, one participant noted that his organization had no problem with employees drinking alcohol, but did not want to see any photos of alcohol in an employee's social media feed.

"There's a big disconnect here. One the one hand, HR professionals view social media as being an 'authentic' version of who people really are; but those same HR professionals are also demanding that people carefully curate how they present themselves on social media."

"It was also clear that people were rarely looking for information related to job tasks - a point some study participants brought up themselves," McDonald says. "And the things they did look for reflected their explicit or implicit biases."

For example, study participants referenced looking for things like posts about hiking and family photos of Christmas. But most people who hike are white, and most people who post Christmas photos are Christians. Study participants also expressed a preference for online profiles that signaled "active" and "energetic" lifestyles, which could lead to discrimination against older or disabled job seekers.

And it was often unclear what job candidates could do to address concerns about bias in cybervetting. For example, while many study participants noted that putting a photo online created the opportunity for bias to affect the hiring process, other study participants noted that not having a "professional" profile picture was in itself a "red flag."

"Some workers have a social media profile that sends the right signals and can take advantage of cybervetting," McDonald says. "But for everyone else, they are not only at a disadvantage, but they don't even know they are at a disadvantage - much less why they are at a disadvantage. Because they don't necessarily know what employers are looking for."

"Some of the people we interviewed were very aware that cybervetting could lead to increased bias; some even avoided cybervetting for that reason," Damarin says. "But others were enthusiastic about its use."

Researchers say one of the key takeaways from the work is that there need to be clear guidelines or best practices for the use of cybervetting, if it is going to be used at all.

"The second takeaway is that the biases and moral judgments we are hearing about from these HR professionals are almost certainly being incorporated into software programs designed to automate the review of job candidates," McDonald says. "These prejudices will simply be baked into the algorithms, making them a long-term problem for both organizations and job seekers."

Credit: 
North Carolina State University

A Skoltech robot analyzes shoppers' behavior

This release has been removed upon request of the submitting institution. Please contact Ilyana Zolotareva, I.Zolotareva@skoltech.ru for more information.

Credit: 
Skolkovo Institute of Science and Technology (Skoltech)

Law enforcement seizures of methamphetamine and marijuana rose during pandemic

An analysis of law enforcement seizures of illegal drugs in five key regions of the United States revealed a rise in methamphetamine and marijuana (cannabis) confiscations during the COVID-19 pandemic. Seizures of the two drugs were higher at their peak in August 2020 than at any time in the year prior to the pandemic. While investigators found that trends in heroin, cocaine and fentanyl seizures were not affected by the pandemic, provisional overdose death data show that the increased drug mortality seen in 2019 rose further through the first half of 2020.

The findings suggest that the pandemic and its related restrictions may have impacted the availability and demand of some, but not all, illegal drugs, and that availability may have increased in summer and fall of 2020 in the five regions included in this study.

The study, published today in Drug and Alcohol Dependence, was supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

"At the beginning of the pandemic, it was unclear how social distancing, travel restrictions and economic hardship in communities would impact drug supply and demand," said Nora D. Volkow, M.D., NIDA director. "Drug seizure data like these give us additional insight into the changing drug use landscape during COVID-19 and may inform our understanding of rising rates of methamphetamine- and opioid-involved overdose deaths during the pandemic."

Measures to address the COVID-19 pandemic have limited social gatherings, closed international borders, and reduced economic activity across many sectors. While provisional data reveal drug overdose deaths have risen during the pandemic, there is little scientific evidence to illuminate the impact of these measures on drug availability and use in the United States.

Seeking answers, investigators led by Joseph J. Palamar, Ph.D., M.P.H., associate professor at the New York University Grossman School of Medicine and co-investigator on the National Drug Early Warning System (NDEWS), mined data on drug seizures by law enforcement. The data were collected through the High Intensity Drug Trafficking Areas program, a grant program aimed at reducing drug trafficking and misuse administered by the Office of National Drug Control Policy in which the Drug Enforcement Administration and the Centers for Disease Control and Prevention play an active role.

Drug seizure data from March 2019 through September 2020 was analyzed in five key U.S. regions: Washington, D.C./Baltimore, Chicago, Ohio, New Mexico, and North Florida. Investigators analyzed 29,574 seizures of five drugs: marijuana, methamphetamine, fentanyl, heroin, and cocaine.

Incidences of marijuana and methamphetamine seizures dipped at the beginning of the pandemic, with low points in April 2020. But confiscations of both substances subsequently rose, exceeding pre-COVID-19 seizure rates and reaching their peaks in August 2020. The quantities of marijuana seized, measured by weight, also climbed significantly from April through September 2020.

While decreases in seizures can indicate decreases in drug availability in communities, it is also possible that decreases may indicate reduced law enforcement during the early months of the pandemic. Study authors noted that it remains unknown if the high post-COVID-19 seizures represent greater drug availability, or whether law enforcement officials were merely 'catching up' regarding previous months of delayed seizures.

Investigators found no significant shifts in the pattern of fentanyl, cocaine, or heroin seizures since the onset of COVID-19, although they emphasize fentanyl seizures have continued to rise steadily from March 2019 through September 2020 irrespective of the pandemic.

"Our understanding of how the COVID-19 pandemic affects drug use is evolving, but we do know that social isolation, even for short periods, can cause psychological distress that may drive some people to seek out psychoactive substances," said Dr. Palamar. "It is critical for us to obtain a clearer picture of how the pandemic has influenced drug supply and demand, so that we may better mitigate potential harmful effects of changing drug use patterns."

The researchers emphasize drug seizure rates are only rough measures of drug availability and use and that additional research is needed to understand how individuals' drug use may be changing during the pandemic. These are critical public health questions, as changes in an individual's drug use--such as abruptly stopping a certain substance or switching to a different one--can increase the chance of drug-related harm, such as withdrawal or overdose. Additionally, further research is needed to assess if patterns observed in these key U.S. regions extend to other parts of the country.

Overdose deaths involving methamphetamine started rising steeply in 2009, and provisional numbers from the CDC show overdose deaths involving stimulant drugs, including methamphetamine, have increased 39% in the year ending in June 2020 compared to the year ending in June 2019. Previous research has found that methamphetamine use has increased significantly among people with an existing opioid use disorder and has disproportionately impacted certain racial and ethnic communities, especially American Indians/Alaska Natives.

Credit: 
NIH/National Institute on Drug Abuse

Indoors, outdoors, 6 feet apart? Transmission risk of airborne viruses can be quantified

image: The chain of infection for a disease whose spread depends on human interactions.

Image: 
Mj Riches

In the 1995 movie "Outbreak," Dustin Hoffman's character realizes, with appropriately dramatic horror, that an infectious virus is "airborne" because it's found to be spreading through hospital vents.

The issue of whether our real-life pandemic virus, SARS-CoV-2, is "airborne" is predictably more complex. The current body of evidence suggests that COVID-19 primarily spreads through respiratory droplets - the small, liquid particles you sneeze or cough, that travel some distance, and fall to the floor. But consensus is mounting that, under the right circumstances, smaller floating particles called aerosols can carry the virus over longer distances and remain suspended in air for longer periods. Scientists are still determining SARS-CoV-2's favorite way to travel.

That the science was lacking on how COVID-19 spreads seemed apparent a year ago to Tami Bond, professor in the Department of Mechanical Engineering and Walter Scott, Jr. Presidential Chair in Energy, Environment and Health. As an engineering researcher, Bond spends time thinking about the movement and dispersion of aerosols, a blanket term for particles light and small enough to float through air ­- whether cigarette smoke, sea spray, or hair spray.

"It quickly became clear there was some airborne component of transmission," Bond said. "A virus is an aerosol. Health-wise, they are different than other aerosols like pollution, but physically, they are not. They float in the air, and their movement depends on their size."

The rush for scientific understanding of the novel coronavirus has focused - understandably - on biological mechanisms: how people get infected, the response of the human body, and the fastest path to a vaccine. As an aerosol scientist, Bond went a different route, convening a team at Colorado State University that would treat the virus like any other aerosol. This team, now published in Environmental Science and Technology, set out to quantify the dynamics of how aerosols like viruses travel from one person to another, under different circumstances.

The cross-section of expertise to answer this question existed in droves at CSU, Bond found. The team she assembled includes epidemiologists, aerosol scientists, and atmospheric chemists, and together they created a new tool for defining how infectious pathogens, including SARS-CoV-2, transport in the air.

Effectively rebreathed air

Their tool is a metric they're calling Effective Rebreathed Volume, or simply, the amount of exhaled air from one person that, by the time it travels to the next person, contains the same number of particles. Treating virus-carrying particles agnostically like any other aerosol allowed the team to make objective, physics-based comparisons between different modes of transmission, accounting for how sizes of particles would affect the number of particles that traveled from one person to another.

They looked at three size categories of particles that cover a biologically relevant range: 1 micron, 10 microns, and 100 microns -- about the width of a human hair. Larger droplets expelled by sneezing would be closer to the 100-micron region. Particles closer to the size of a single virion would be in the 1-micron region. Each have very different air-travel characteristics, and depending on the size of the particles, different mitigation measures would apply, from opening a window, to increasing fresh air delivery with through an HVAC system.

They compiled a set of models to compare different scenarios. For example, the team compared the effective rebreathed volume of someone standing outdoors 6 feet away, to how long it would take someone to rebreathe the same amount of air indoors but standing farther away.

Confinement matters

The team found that distancing indoors, even 6 feet apart, isn't enough to limit potentially harmful exposures, because confinement indoors allows particle volumes to build up in the air. Such insights aren't revelatory, in that most people avoid confinement in indoor spaces and generally feel safer outdoors. What the paper shows, though, is that the effect of confinement indoors and subsequent particle transport can be quantified, and it can be compared to other risks that people find acceptable, Bond said.

Co-authors Jeff Pierce in atmospheric science and Jay Ham in soil and crop sciences helped the team understand atmospheric turbulence in ways that could be compared in indoor and outdoor environments.

Pierce said he sought to constrain how the virus-containing particles disperse as a function of distance from the emitting person. When the pandemic hit last year, the public had many questions about whether it was safe to run or bike on trails, Pierce said. The researchers found that longer-duration interactions outdoors at greater than 6-foot distances appeared safer than similar-duration indoor interactions, even if people were further apart indoors, due to particles filling the room rather than being carried away by wind.

"We started fairly early on in the pandemic, and we were all filled with questions about: 'Which situations are safer than others?' Our pooled expertise allowed us to find answers to this question, and I learned a lot about air filtration and air exchange in my home and in my CSU classroom," Pierce said.

More to learn

What remains unclear is which size particles are most likely to cause COVID-19 infection.

Viruses can be carried on droplets large and small, but there is likely a "sweet spot" between droplet size; ability to disperse and remain airborne; and desiccation time, all of which factor into infective potential, explained Angela Bosco-Lauth, paper co-author and assistant professor in biomedical sciences.

The paper includes an analysis of the relative infection risk of different indoor and outdoor scenarios and mitigation measures, depending on the numbers of particles being inhaled.

"The problem we face is that we still don't know what the infectious dose is for people," Bosco-Lauth said. "Certainly, the more virus present, the higher the risk of infection, but we don't have a good model to determine the dose for people. And quantifying infectious virus in the air is tremendously difficult."

Follow-up pursuits

The team is now pursuing follow-up questions, like comparing different mitigation measures for reducing exposures to viruses indoors. Some of these inquiries fall into the category of "stuff you already know, but with numbers," Bond said. "People are now thinking, OK, more ventilation is better, or remaining outside is better, but there is not a lot of quantification and numbers behind those recommendations," Bond said.

Bond hopes the team's work can lay a foundation for more up-front quantification of transmission dynamics in the unfortunate event of another pandemic. "This time, there was a lot of guessing at the beginning, because the science of transmission wasn't fully developed," she said. "There shouldn't be a next time."

Credit: 
Colorado State University

Novel drug prevents amyloid plaques, a hallmark of Alzheimer's disease

image: In this artist's rendering, amyloid plaques are interspersed among neurons. These aggregates of misfolded proteins disrupt and kill brain cells, and are a hallmark of Alzheimer's disease.

Image: 
National Institute of Aging

Amyloid plaques are pathological hallmarks of Alzheimer's disease (AD) -- clumps of misfolded proteins that accumulate in the brain, disrupting and killing neurons and resulting in the progressive cognitive impairment that is characteristic of the widespread neurological disorder.

In a new study, published March 2, 2021 in the Journal of Experimental Medicine (JEM), researchers at University of California San Diego School of Medicine, Massachusetts General Hospital and elsewhere have identified a new drug that could prevent AD by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques.

In studies using rodents and monkeys, the researchers report the drug was found to be safe and effective, paving the way for possible clinical trials in humans.

"Alzheimer's disease is an extraordinarily complex and multi-faceted condition that has, so far, defied effective treatment, let alone prevention," said senior author Steven L. Wagner, PhD, professor in the Department of Neurosciences at UC San Diego School of Medicine. "Our findings suggest a potential therapy that might prevent one of the key elements of AD."

Amyloid plaques are composed of small protein fragments called amyloid beta (Aβ) peptides. These peptides are generated by enzymes called β-secretase and γ-secretase, which sequentially cleave a protein called amyloid precursor protein on the surfaces of neurons to release Aβ fragments of varying lengths. Some of these fragments, such as Aβ42, are particularly prone to forming plaques, and their production is elevated in patients with mutations predisposing them to early-onset AD.

Several attempts have been made to treat or prevent AD using drugs that inhibit either β-secretase or γ-secretase, but many of these drugs have proved to be highly toxic or unsafe in humans, likely because β-secretase and γ-secretase are required to cleave additional proteins in the brain and other organs.

Instead, Wagner and colleagues investigated the therapeutic potential of drugs known as γ-secretase modulators or GSMs, which instead of inhibiting the γ-secretase enzyme, slightly alter its activity so that it produces fewer Aβ peptides that are prone to form plaques while continuing to duties cleaving other protein targets.

"GSMs offer the ability to mitigate mechanism-based toxicities associated with γ-secretase inhibitors," said Wagner.

In the new JEM study, researchers created a novel GSM and tested it on mice, rats and macaques. They found that repeated, low doses of the GSM eliminated Aβ42 production in mice and rats, without causing any toxic side effects. The drug was also safe and effective in macaques, reducing Aβ42 levels by up to 70 percent.

The novel GSM was then tested in a mouse model of early-onset AD, treating the animals either before or shortly after they began to form amyloid plaques. In both cases, the novel GSM decreased plaque formation and reduced plaque-associated inflammation, which is thought to contribute to the development of disease.

The findings suggest that the novel GSM could be used prophylactically to prevent AD, write the authors, either in patients with genetic mutations that increase susceptibility to AD or in cases where amyloid plaques have been detected by brain scans.

"In this study, we have pharmacologically characterized a potent GSM that, based on its preclinical attributes, appears to equal or exceed the potency of any previously tested GSMs," said co-author Rudolph Tanzi, PhD, professor neurology at Harvard Medical School and director of the Genetics and Aging Research Unit at Massachusetts General Hospital.

"Future clinical trials will determine whether this promising GSM is safe in humans and could be used to effectively treat or prevent Alzheimer's disease."

An estimated 5 million Americans are living with AD. The number of people with AD doubles every five years beyond age 65, according to the Centers for Disease Control, with the total number of Americans with the disease projected to nearly triple to 14 million by 2060. Currently, there is no known cure, only symptomatic therapies.

Credit: 
University of California - San Diego

Food for thought: New maps reveal how brains are kept nourished

image: Newly developed brain maps with unprecedented detail are helping answer critical questions about brain blood flow. These new maps offer resolution finer than a millionth of a meter, reconstructed here with high microvessel density areas in red, intermediate density areas in white and low density areas in blue.

Image: 
Xiang Ji and Edmund O'Donnell, UC San Diego

Our brains are non-stop consumers. A labyrinth of blood vessels, stacked end-to-end comparable in length to the distance from San Diego to Berkeley, ensures a continuous flow of oxygen and sugar to keep our brains functioning at peak levels.

But how does this intricate system ensure that more active parts of the brain receive enough nourishment versus less demanding areas? That's a century-old problem in neuroscience that scientists at the University of California San Diego have helped answer in a newly published study.

Studying the brains of mice, a team of researchers led by Xiang Ji, David Kleinfeld and their colleagues has deciphered the question of brain energy consumption and blood vessel density through newly developed maps that detail brain wiring to a resolution finer than a millionth of a meter, or one-hundredth of the thickness of a human hair.

A result of work at the crossroads of biology and physics, the new maps provide novel insights into these "microvessels" and their various functions in blood supply chains. The techniques and technologies underlying the results are described March 2 in the journal Neuron.

"We developed an experimental and computational pipeline to label, image and reconstruct the microvascular system in whole mouse brains with unprecedented completeness and precision," said Kleinfeld, a professor in the UC San Diego Department of Physics (Division of Physical Sciences) and Section of Neurobiology (Division of Biological Sciences). Kleinfeld says the effort was akin to reverse engineering nature. "This allowed Xiang to carry out sophisticated calculations that not just related brain energy use to vessel density, but also predicted a tipping point between the loss of brain capillaries and a sudden drop in brain health."

Questions surrounding how blood vessels carry nourishment to active and less active regions were posed as a general issue in physiology as far back as 1920. By the 1980s, a technology known as autoradiography, the predecessor of modern-day positron emission tomography (PET), allowed scientists to measure the distribution of sugar metabolism across the mouse brain.

To fully grasp and solve the problem, Ji, Kleinfeld and their colleagues at the Howard Hughes Medical Institute's Janelia Research Campus and UC San Diego Jacobs School of Engineering filled 99.9 percent of the vessels in the mouse brain--a count of nearly 6.5 million--with a dye-labeled gel. They then imaged the full extent of the brain with sub-micrometer precision. This resulted in fifteen trillion voxels, or individual volumetric elements, per brain, that were transformed into a digital vascular network that could be analyzed with the tools of data science.

With their new maps in hand, the researchers determined that the concentration of oxygen is roughly the same in every region of the brain. But they found that small blood vessels are the key components that compensate for varying energy requirements. For example, white matter tracts, which transfer nerve impulses across the two brain hemispheres and to the spinal cord, are regions of low energy needs. The researchers identified lower levels of blood vessels there. By contrast, brain regions that coordinate the perception of sound use three times more energy and, they discovered, were found with a much greater level of blood vessel density.

"In the era of increasing complexities being unraveled in biological systems, it is fascinating to observe the emergence of shared simple and quantitative design rules underlaying the seemingly complicated networks across mammalian brains," said Ji, a graduate student in physics.

Up next, the researchers hope to drill down into the finer aspects of their new maps to determine the detailed patterns of blood flow into and out from the entire brain. They will also pursue the largely uncharted relationship between the brain and the immune system.

Credit: 
University of California - San Diego